Skip to content
Year-End Sale is Live Now - Up to 50% off
New users? Get 5% off on your first purchase.
Free US shipping over $100
Year-End Sale is Live Now - Up to 50% off
New users? Get 5% off on your first purchase.
Free US shipping over $100
Bacteriostatic Water Injection Multiple Dose Vials 30 mL, 25Pack (Rx)

Pfizer's Unprecedented Price Hike on Bacteriostatic Water Sodium Chloride and Lidocaine Expected May 15th 2025

In a surprising move, Pfizer has announced significant price increases set to take effect on May 15th, 2025, affecting several essential medical supplies. This adjustment is part of a broader strategy that includes the "Pfizer Price Increases" initiative, which aims at recalibrating their pricing structure across various pharmaceutical products.

Price Increase on Bacteriostatic Water

One of the most notable changes is the tripling in price of Bacteriostatic Water. This product, used primarily in medical settings for diluting or dissolving medications for intramuscular (IM), intravenous (IV), or subcutaneous injection, is crucial for healthcare providers. The upcoming "Price of Bacteriostatic Water Tripling In Price" poses a challenge for medical facilities that rely on this cost-effective solution.

For those interested in the specific Bacteriostatic Water product affected by this increase, the Bacteriostatic Water Injection Multiple Dose Vials 30 mL, 25/Pack (Rx) provides essential functions with sterile, non-pyrogenic properties, containing 0.9% benzyl alcohol as its antibacterial agent.

Price Increase on Sodium Chloride for Injection

The injection solution, Sodium Chloride, is also subject to price adjustments. Known for its role in hydration and medication mixing, this "Price Increase on Sodium Chloride for Injection" presents a critical shift for patients and healthcare facilities.

Price Increase on Lidocaine 1% and 2% for Injection

Additionally, Lidocaine, a vital anesthetic used in various medical procedures, will see its price increased. The "Price Increase on Lidocaine 1% and 2% for Injection" is part of Pfizer's broader pricing initiative. These increments will affect the affordability of local anesthesia in operations and outpatient treatments.

With these price changes nearing, it is vital for healthcare providers to plan accordingly and adjust their supply budgets in preparation. While Pfizer's move may stir some concern, it underscores the importance of proactive financial management in medical procurement.

For more details on these changes or inquiries on other medical supplies, you can visit our main website Mountainside Medical. Stay informed on upcoming changes and prepare for an adaptive healthcare environment.

Previous article US Funding in Stem Cell Research Explained